216 related articles for article (PubMed ID: 25085576)
1. Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.
Tringali C; Silvestri I; Testa F; Baldassari P; Anastasia L; Mortarini R; Anichini A; López-Requena A; Tettamanti G; Venerando B
BMC Cancer; 2014 Aug; 14():560. PubMed ID: 25085576
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
Ruan S; Lloyd KO
Cancer Res; 1992 Oct; 52(20):5725-31. PubMed ID: 1394196
[TBL] [Abstract][Full Text] [Related]
3. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C
Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM3:GD3 ratio as an index for the management of melanoma.
Ravindranath MH; Tsuchida T; Morton DL; Irie RF
Cancer; 1991 Jun; 67(12):3029-35. PubMed ID: 2044049
[TBL] [Abstract][Full Text] [Related]
5. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.
Kanda S; Cochran AJ; Lee WR; Morton DL; Irie RF
Int J Cancer; 1992 Nov; 52(5):682-7. PubMed ID: 1428227
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
[TBL] [Abstract][Full Text] [Related]
7. Correlation of gangliosides GM2 and GM3 with metastatic potential to lungs of mouse B16 melanoma.
Saha S; Mohanty KC
J Exp Clin Cancer Res; 2003 Mar; 22(1):125-34. PubMed ID: 12725332
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of gangliosides in malignant properties of melanomas.
Ohmi Y; Kambe M; Ohkawa Y; Hamamura K; Tajima O; Takeuchi R; Furukawa K; Furukawa K
PLoS One; 2018; 13(11):e0206881. PubMed ID: 30462668
[TBL] [Abstract][Full Text] [Related]
9. Chemical, metabolic and immunological characterization of gangliosides of human glioma cells.
Maeda Y; Yamaki T; Yoshikawa J; Tatewaki K; Piao H; Yu H; Ibayashi Y; Hashi K
Cancer Biochem Biophys; 1998 Nov; 16(4):313-32. PubMed ID: 9925280
[TBL] [Abstract][Full Text] [Related]
10. Gangliosides of human melanoma.
Tsuchida T; Saxton RE; Morton DL; Irie RF
Cancer; 1989 Mar; 63(6):1166-74. PubMed ID: 2917320
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.
Ramos RI; Bustos MA; Wu J; Jones P; Chang SC; Kiyohara E; Tran K; Zhang X; Stern SL; Izraely S; Sagi-Assif O; Witz IP; Davies MA; Mills GB; Kelly DF; Irie RF; Hoon DSB
Mol Oncol; 2020 Aug; 14(8):1760-1778. PubMed ID: 32358995
[TBL] [Abstract][Full Text] [Related]
12. Metabolic processing of gangliosides by normal and Salla human fibroblasts in culture. A study performed by administering radioactive GM3 ganglioside.
Chigorno V; Tettamanti G; Sonnino S
J Biol Chem; 1996 Sep; 271(36):21738-44. PubMed ID: 8702969
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc:LacCer alpha 2-3 sialyltransferase (GM3 synthase).
Zebda N; Pedron S; Rebbaa A; Portoukalian J; Berthier-Vergnes O
FEBS Lett; 1995 Apr; 362(2):161-4. PubMed ID: 7720864
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GD2 in reception and transduction of cell death signal in tumor cells.
Doronin II; Vishnyakova PA; Kholodenko IV; Ponomarev ED; Ryazantsev DY; Molotkovskaya IM; Kholodenko RV
BMC Cancer; 2014 Apr; 14():295. PubMed ID: 24773917
[TBL] [Abstract][Full Text] [Related]
15. Analysis of melanoma cells stably transfected with beta 1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression.
Ruan S; Raj BK; Furukawa K; Lloyd KO
Arch Biochem Biophys; 1995 Oct; 323(1):11-8. PubMed ID: 7487055
[TBL] [Abstract][Full Text] [Related]
16. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells.
Ruan S; Raj BK; Lloyd KO
J Neurochem; 1999 Feb; 72(2):514-21. PubMed ID: 9930722
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides of normal and neoplastic human melanocytes.
Carubia JM; Yu RK; Macala LJ; Kirkwood JM; Varga JM
Biochem Biophys Res Commun; 1984 Apr; 120(2):500-4. PubMed ID: 6732768
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.
Mirkin BL; Clark SH; Zhang C
Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645
[TBL] [Abstract][Full Text] [Related]
19. Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides.
Miyata M; Kambe M; Tajima O; Moriya S; Sawaki H; Hotta H; Kondo Y; Narimatsu H; Miyagi T; Furukawa K; Furukawa K
Cancer Sci; 2011 Dec; 102(12):2139-49. PubMed ID: 21895867
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of melanoma-associated gangliosides in cancer patients.
Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
